Medicines360 is proud to make an important announcement about LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg
CLICK HERE TO READ THE PRESS RELEASEIn April 2021, the levonorgestrel-releasing intrauterine device (IUD) also known as the hormonal IUD or hormonal intrauterine system (IUS) was added to the U.S. Agency for International Development (USAID)’s Product Catalog for the first time. This milestone was made possible thanks to support from the Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project, […]
LIFE SCIENCE LEADER – You might think a market made of half the human beings on this planet would attract any amount of investment. Why is it, then, that most women lack access to essential medicines? Why does it take a nonprofit model to even begin bringing access to such a large population in a […]
SANTA BARBARA INDEPENDENT – Direct Relief’s Kirchmaier Volunteer Center was standing room only Friday morning, March 8, as more than 150 people gathered in honor of International Women’s Day to celebrate achievements and acknowledge remaining hurdles, including the lack of global access to affordable maternal health care. This year’s theme was “balance for better — […]
FORBES – Medicines360, the non-profit pharmaceutical company behind the hormonal IUD Liletta, is on a mission to increase women’s access to reproductive care around the world. This month, the female-led company announced the launch of Avibela, a hormonal IUD, in Madagascar.
Jessica Grossman, M.D., CEO of Medicines360, wants to empower women when it comes to choices surrounding their reproductive healthcare.
Jessica Grossman, M.D., is a fan of the calculated risk. Taking one to change careers after medical school landed her in a role that is helping shape the future of women’s healthcare.
SANTA BARBARA INDEPENDENT – Direct Relief’s Kirchmaier Volunteer Center was standing room only Friday morning, March 8, as more than 150 people gathered in honor of International Women’s Day to celebrate achievements and acknowledge remaining hurdles, including the lack of global access to affordable maternal health care. This year’s theme was “balance for better — […]
Strategic alliance will increase engagement with U.S. public health clinics and their patients about hormonal IUDs (long-acting reversible contraceptives, or LARCs) SAN FRANCISCO and CHARLESTON, S.C. – Medicines360 and Afaxys Pharma, LLC, two mission-driven, socially conscious women’s health pharmaceutical companies, today announced their collaboration to promote Medicines360’s intrauterine system (IUS), LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg, which is […]
FORBES – Medicines360, the non-profit pharmaceutical company behind the hormonal IUD Liletta, is on a mission to increase women’s access to reproductive care around the world. This month, the female-led company announced the launch of Avibela, a hormonal IUD, in Madagascar.
